tiprankstipranks
Trending News
More News >
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Japanese Market

Taiko Pharmaceutical Co., Ltd. (4574) Financial Statements

Compare
0 Followers

Taiko Pharmaceutical Co., Ltd. Financial Overview

Taiko Pharmaceutical Co., Ltd.'s market cap is currently ¥14.92B. The company's EPS TTM is ¥5.05; its P/E ratio is 17.20; Taiko Pharmaceutical Co., Ltd. is scheduled to report earnings on February 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 6.40B¥ 6.29B¥ 6.12B¥ 5.04B¥ 10.72B
Gross Profit¥ 3.48B¥ 3.67B¥ 2.58B¥ 1.08B¥ 2.75B
Operating Income¥ 459.00M¥ 629.00M¥ -1.00B¥ -3.08B¥ -4.95B
EBITDA¥ 724.00M¥ 882.00M¥ -2.85B¥ -3.75B¥ -5.57B
Net Income¥ 923.00M¥ 898.00M¥ -3.61B¥ -4.89B¥ -9.59B
Balance Sheet
Cash & Short-Term Investments¥ 4.26B¥ 4.53B¥ 5.48B¥ 3.50B¥ 6.10B
Total Assets¥ 12.27B¥ 12.91B¥ 13.22B¥ 15.05B¥ 22.54B
Total Debt¥ 816.00M¥ 2.03B¥ 3.25B¥ 3.81B¥ 4.77B
Net Debt¥ -3.44B¥ -2.50B¥ -2.23B¥ 704.00M¥ -1.02B
Total Liabilities¥ 3.75B¥ 4.95B¥ 6.48B¥ 7.00B¥ 9.73B
Stockholders' Equity¥ 8.52B¥ 7.96B¥ 6.74B¥ 8.04B¥ 12.80B
Cash Flow
Free Cash Flow¥ 523.00M¥ 205.00M¥ -421.00M¥ -2.08B¥ -3.19B
Operating Cash Flow¥ 814.00M¥ 362.00M¥ -307.00M¥ -1.99B¥ -1.59B
Investing Cash Flow¥ 142.00M¥ -5.00M¥ 1.17B¥ 190.00M¥ -1.62B
Financing Cash Flow¥ -1.23B¥ -1.18B¥ 1.54B¥ -997.00M¥ 3.96B
Currency in JPY

Taiko Pharmaceutical Co., Ltd. Earnings and Revenue History

Taiko Pharmaceutical Co., Ltd. Debt to Assets

Taiko Pharmaceutical Co., Ltd. Cash Flow

Taiko Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS